$1,853Thousand | No. of Holdings #10
CAXTON CORP Performance
| Ticker | $ Bought |
|---|---|
| space exploration techn corp | 445,346 |
| alphabet inc | 246,906 |
| vanguard index fds | 233,094 |
| blackstone inc | 188,218 |
| Ticker | % Inc. |
|---|---|
| lexeo therapeutics inc | 21.65 |
| berkshire hathaway inc del | 3.71 |
| Ticker | % Reduced |
|---|---|
| kyverna therapeutics inc | -34.23 |
| Ticker | $ Sold |
|---|---|
| spdr gold tr | -3,279,920 |
CAXTON CORP has about 67.1% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 67.1 |
| Communication Services | 13.3 |
| Financial Services | 10.2 |
| Healthcare | 9.4 |
CAXTON CORP has about 23.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 67.1 |
| MEGA-CAP | 13.3 |
| LARGE-CAP | 10.2 |
| MICRO-CAP | 5.5 |
| SMALL-CAP | 3.9 |
About 29.8% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 70.3 |
| S&P 500 | 23.5 |
| RUSSELL 2000 | 6.3 |
| Top 5 Losers (%) | % | |
|---|---|---|
lexeo therapeutics inc | -17.5 % | |
| Top 5 Losers ($) | $ | |
|---|---|---|
lexeo therapeutics inc | 0.0 M | |
This heatmap illustrates the top 50 positions within the fund's portfolio.
CAXTON CORP has 10 stocks in it's portfolio. proved to be the most loss making stock for the portfolio. was the most profitable stock for CAXTON CORP last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Alx Oncology Hldgs Inc CAXTON CORP's holding in Alx Oncology Hldgs Inc over time | 2.34% | 20,946 | $43.4K 2.34% | 0%unchanged 0 percentunchanged | |
Blackstone Inc CAXTON CORP's holding in Blackstone Inc over time | 10.15% | 1,597 | $188.2K 10.15% | Newnew position | |
GLD Spdr Gold TrSpdr Gold TrGLD | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Alphabet Inc Alphabet IncGOOG CAXTON CORP's holding in Alphabet Inc over time | 13.32% | 691 | $246.9K 13.32% | Newnew position | |
Inhibikase Therapeutics Inc CAXTON CORP's holding in Inhibikase Therapeutics Inc over time | 3.12% | 28,453 | $57.8K 3.12% | 0%unchanged 0 percentunchanged | |
VB Vanguard Index FdsVanguard Index FdsVB | 12.58% | 339 | $233.1K 12.58% | Newnew position | |
X4 Pharmaceuticals Inc CAXTON CORP's holding in X4 Pharmaceuticals Inc over time | 3.92% | 15,557 | $72.7K 3.92% | 0%unchanged 0 percentunchanged | |
Put Space Exploration Techn CorpSpace Exploration Techn Corp | 24.03% | 2,606 | $445.3K 24.03% | Newnew position | |
Cl B New Berkshire Hathaway Inc DelBerkshire Hathaway Inc Del | 20.35% | 754 | $377.1K 20.35% | 3.71%increased 3.71 percentadded | |
Com Kyverna Therapeutics IncKyverna Therapeutics Inc | 5.93% | 12,347 | $110.0K 5.93% | 34.23%decreased 34.23 percentreduced | |
Com Lexeo Therapeutics IncLexeo Therapeutics Inc | 4.26% | 16,962 | $79.0K 4.26% | 21.65%increased 21.65 percentadded | |